Ascent Group, LLC Astrazeneca PLC Transaction History

Ascent Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$63.15 - $71.6 $14,777 - $16,754	-234 Reduced 5.69%	3,877 $269,000
Q4 2022 Feb 16, 2023	BUY	$54.21 - $70.44 $9,866 - $12,820	182 Added 4.63%	4,111 $278,000
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $131,065 - $335,574	-2,472 Reduced 38.62%	3,929 $231,000
Q2 2022 Aug 05, 2022	SELL	$59.26 - $71.14 $20,622 - $24,756	-348 Reduced 5.16%	6,401 $424,000
Q1 2022 May 10, 2022	BUY	$55.72 - $67.12 $58,227 - $70,140	1,045 Added 18.32%	6,749 $448,000
Q4 2021 Mar 01, 2022	BUY	$54.02 - $63.83 $308,130 - $364,086	5,704 New	5,704 $337,000

1,368

475M

6.08M

4.44M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $226B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Ascent Group, LLC with notifications on news.